Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer

NCT00004175 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Northwestern University

Collaborators